![](/img/cover-not-exists.png)
Ticlopidine pretreatment before coronary stenting is associated with sustsained decrease of adverse cardiac events: data from the evaluation of platelet IIb/IIIa inhibitor for stenting (EPISTENT trial)
R Steinhubl, S.G Ellis, K Wolski KVolume:
10
Year:
2001
Language:
english
DOI:
10.1016/s1062-1458(01)00402-0
File:
PDF, 37 KB
english, 2001